{"id":"W2891010170","doi":"10.1200/jco.2018.36.15_suppl.4112","title":"A phase II study of pre- and post-operative gemcitabine and erlotinib plus pancreaticoduodenectomy (PD) for patients with resectable pancreatic ductal adenocarcinoma (PDAC): ACOSOG Z5041 trial (Alliance).","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; University of Toronto","funders":"","keywords":"Medicine; Gemcitabine; Clinical endpoint; Erlotinib; Surgery; Perioperative; Phases of clinical research; Urology; Internal medicine; Oncology; Cancer; Chemotherapy; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002506542,0.001828294,0.001666291,0.0004955992,0.0003618271,0.0009729693,0.0009446078,0.001491382,0.004321166],"category_scores_gemma":[0.001031269,0.0007795113,0.001523943,0.000540112,0.001170864,0.0007720087,0.0005000829,0.002740466,0.001024171],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008515916,"about_ca_system_score_gemma":0.001811282,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008553421,"about_ca_topic_score_gemma":0.002255156,"domain_scores_codex":[0.999458,0.0002991631,0.00002852026,0.00008342886,0.00004096052,0.0000899521],"domain_scores_gemma":[0.9991021,0.0001348298,0.0001989293,0.00008982588,0.00004539153,0.0004289708],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9062814,0.04088808,0.005900033,0.0007013502,0.0009195725,0.0001489642,0.0001467958,0.001061771,0.01224643,0.0001333441,0.001861884,0.02971024],"study_design_scores_gemma":[0.7795316,0.2089546,0.008356065,0.00002686003,0.0004475207,0.000130923,0.00003772236,0.0003980026,0.0007473218,0.0001043176,0.001248389,0.00001668688],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926282,0.001452939,0.0002891188,0.0004208647,0.000131795,0.002786622,0.001038032,0.0000564984,0.001195895],"genre_scores_gemma":[0.9846407,0.00203543,0.001298654,0.00126518,0.0002545744,0.004015035,0.003879679,0.00002735453,0.002583425],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004321166,"threshold_uncertainty_score":0.01445574,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09613788876951203,"score_gpt":0.481383469703807,"score_spread":0.385245580934295,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}